If your plan stopped paying for your medicine, you don’t have to start over. Insurance can still pay for your physician visits, and we’ll walk you through every way to keep your medicine going.
Book my consultationMost major insurance accepted, plus convenient cash pay options.
Losing coverage for the medicine doesn’t mean losing your physician. Here’s how people keep going.
Your visits with an obesity medicine physician are billed to your insurance, and you pay any copay. We check your coverage before your first visit.
Novo Nordisk and Lilly sell Wegovy, Zepbound and Foundayo directly at cash prices. Your physician sends the prescription and helps you weigh the price at the dose you’re likely to stay on.
One price covers compounded medicine, prepared for you by a state-licensed pharmacy, plus shipping, your consultations and messages with your care team. See the plans.
Coverage rules changed for 2027, and some plans still cover the medicine with new conditions. We’ll look at yours with you.
Some plans now ask for a prior authorization or a lifestyle program before they cover a GLP-1. Our guide to GLP-1 coverage in 2027 explains what changed and what to ask.
If brand-name medicine is right for you, we handle the prior authorization as a concierge service, including the appeal if your plan says no. We also help with manufacturer copay assistance.
If your commercial plan still covers the medicine, maker savings cards can bring the cost to as little as $25 a month, with savings caps. They aren’t available to people with government coverage.
The Medicare GLP-1 Bridge costs $50 a month for people who qualify, from July 1, 2026 to December 31, 2027, and we prescribe through it. See Medicare and GLP-1 medication.
What each maker’s own program charged when we checked in November 2026. Every program needs a prescription, and prices can change, so check the program’s site before you order.
| Medicine | Where | Cash price, as of November 2026 |
|---|---|---|
| Wegovy pillsemaglutide, once a day | NovoCare | $149 a month at 1.5 mg, $199 at 4 mg, $299 at 9 mg and 25 mg. |
| Wegovy pensemaglutide, once a week | NovoCare | $199 a month for a new patient’s first two fills of 0.25 mg and 0.5 mg through December 31, 2026, then $349. Wegovy 7.2 mg $399. |
| Foundayoorforglipron, once a day | LillyDirect | $149 a month for 0.8 mg and 2.5 mg, $199 for 5.5 mg, $299 for 9 mg, and $299 for 14.5 mg and 17.2 mg with a refill within 45 days. The 2.5 mg and 5.5 mg prices are temporary through December 31, 2026, and regular prices run $149 to $349 by dose. |
| Zepbound vialstirzepatide, once a week | LillyDirect | $299 (2.5 mg), $399 (5 mg), $449 (7.5 mg to 15 mg with a refill within 45 days; $499 for 7.5 mg and $699 for 10 to 15 mg otherwise), per 4 vials (28 days). |
TrumpRx lists Wegovy pill from $149, Wegovy pen from $199 and Zepbound from $299 a month, as of November 2026. For every dose and what to check before you pay, see our GLP-1 cash price guide.
If brand-name medicine is out of reach, a self-pay plan keeps your medicine and your care together. Your physician decides with you whether compounded medicine is right for you.
$158.33 per 4 weeks equivalent. Or $200 every 4 weeks.
$225 per 4 weeks equivalent. Or $300 every 4 weeks.
Compounded medicines are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. They are not the same as, or generic versions of, Wegovy, Ozempic, Zepbound or Mounjaro. Your physician talks with you about this and about every alternative.
Self-pay plans aren’t offered at 65 and over. If you have Medicare, see Medicare and GLP-1 medication.
Book my consultation
Answer a few questions and add your insurance. We check your coverage before your first visit.
By video, or in person in Deer Park, IL. Bring your history, your current dose and your questions.
Insurance for your visits and the maker’s cash price for the medicine, or a self-pay plan. Your physician helps you weigh both.
Follow-ups, dose adjustments and messages with your care team in the app.
Have other questions? Call (312) 625-1889 or email support@aayuwell.com.
Yes. Your visits with your physician are billed to your insurance, and you pay any copay. You then buy brand-name medicine at the maker’s cash price. If you choose a self-pay plan instead, your consultations are part of the plan price.
As of November 2026, the Wegovy pill starts at $149 a month cash at the starting dose, and Zepbound vials on LillyDirect start at $299 for 4 vials (28 days) at 2.5 mg. For most of these medicines the price rises with the dose. Our GLP-1 cash price guide lists every dose.
One price for compounded medicine, shipping, your consultations and messages with your care team. Compounded semaglutide is $475 for 12 weeks or $200 every 4 weeks. Compounded tirzepatide is $675 for 12 weeks or $300 every 4 weeks. The medicine is prepared for you by a state-licensed pharmacy. Compounded medicines are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Your physician reviews your health history, your current dose and how you’ve been doing, then decides with you whether a change makes sense and how to make it safely. Compounded medicines are not the same as Wegovy or Zepbound, so it’s a medical decision, not just a price one.
Self-pay plans aren’t offered at 65 and over. If you have Medicare, your visits are billed to Medicare, and we prescribe through the Medicare GLP-1 Bridge for people who qualify, at $50 a month from July 1, 2026 to December 31, 2027. See Medicare and GLP-1 medication.
Your first consultation is waived. A $50 fee applies if you’re prescribed medicine and decide not to start. There’s no fee to cancel, and a $35 fee applies to a missed appointment, with your first one waived.
Scan with your phone's
camera to download

*Insurance coverage varies by plan. Prior authorization may be required. Medicine is prescribed only when your physician decides it is right for you. Outside prices come from each maker’s program as of November 2026 and can change at any time. Compounded medicines are prepared by a state-licensed pharmacy; they are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Individual results vary. See our Terms & Conditions for full details.